COMPANIES COVERED
3SBioDownload FREE Report Sample
Download Free sampleThe process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
rhEPO Market contains market size and forecasts of rhEPO in global, including the following market information:
Global rhEPO Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global rhEPO Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five rhEPO companies in 2021 (%)
The global rhEPO market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ESRD Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of rhEPO include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the rhEPO manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global rhEPO Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global rhEPO Market Segment Percentages, by Type, 2021 (%)
ESRD
Cancer
HIV
Wounds and neural disease
Global rhEPO Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global rhEPO Market Segment Percentages, by Application, 2021 (%)
Hospitals
Retail Pharmacies
Global rhEPO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global rhEPO Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies rhEPO revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies rhEPO revenues share in global market, 2021 (%)
Key companies rhEPO sales in global market, 2017-2022 (Estimated), (K MT)
Key companies rhEPO sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
